ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

DCPC Planning 10 More Prevention Fellowship Awards

August 14, 1987

Breast Cancer Reports “Informative,” More Research Is Needed: Gullino

December 3, 1976

Letter to the Editors: Scientists, Media Shouldn’t Overstate “Breakthroughs”

May 29, 1998

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

December 22, 2006

High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer

November 27, 2009

Upton Wraps Up Reorganization – DCCR Revamped, No Prevention Division

October 12, 1979